News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
jjj
Preparation is key: brief checklist how to bring IVD MD into compliance with EU IVDR
El IVDR evolucionó a partir de la IVDD para establecer un “marco más sólido, transparente,…
foto informe asebio 2020
2020 AseBio Report shows huge jump in Spanish biotechnology in pandemic year
Biotech companies launched 70% more products and services to market and Spain moved to eighth in…
Moirai Biodesign Team
Moirai Biodesign creates an innovative synthetic RNA design software
Healthcare · Drug discovery · Advanced therapies
Moirai Biodesign – a biotech startup located at the Barcelona Scientific Park, pioneer in the…
edificio oryzon
ORYZON to present new clinical data and corporate updates at international conferences in June and July
Healthcare
Emerging Biotech Company Showcase organizado por NewYorkBIO y la Bolsa de Nueva York Spring…
kally wong
#NewMember | "AseBio allows to know the latest market trends and connect with the Spanish biotech industry"
Healthcare
Meet our new memeber DSM Pentapharm. We talk with Kally Wong,  con la …
CENER
More than 160 spanish biotech companies seek out solutions for a greener industry
Industrial biotechnology · BioSpain
Most of these companies will be at the most important annual event for the sector, BIOSPAIN 2021,…
foto oryzon
ORYZON announces FDA approval of IND for PORTICO, a Phase IIb trial with vafidemstat in Borderline Personality Disorder
Healthcare
Recruitment ongoing in Europe. Primary objectives: to assess the effect of vafidemstat to…
foto oryzon 2
ORYZON presents iadademstat ALICE 30-month data at EHA-2021, confirming positive and robust efficacy in combination with azacitidine in AML
Healthcare
Robust signals of clinical efficacy, with ORR of 83%, of which 67% are CR/CRi and five…
biodesayuno foto
BIOSPAIN represents a boost for investment in a decisive year for biotechnology
BioSpain · Financing · Communication
The pandemic has provided an opportunity for Spanish biotechnology and private investment has…